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The maintenance and regulation of proteostasis is a critical function for post-mitotic
neurons and its dysregulation is increasingly implicated in neurodegenerative diseases.
Despite having different clinical manifestations, these disorders share similar pathology;
an accumulation of misfolded proteins in neurons and subsequent disruption to cellular
proteostasis. The endoplasmic reticulum (ER) is an important component of proteostasis,
and when the accumulation of misfolded proteins occurs within the ER, this disturbs ER
homeostasis, giving rise to ER stress. This triggers the unfolded protein response (UPR),
distinct signaling pathways that whilst initially protective, are pro-apoptotic if ER stress
is prolonged. ER stress is increasingly implicated in neurodegenerative diseases, and
emerging evidence highlights the complexity of the UPR in these disorders, with both
protective and detrimental components being described. Protein Disulfide Isomerase
(PDI) is an ER chaperone induced during ER stress that is responsible for the formation
of disulfide bonds in proteins. Whilst initially considered to be protective, recent studies
have revealed unconventional roles for PDI in neurodegenerative diseases, distinct from
its normal function in the UPR and the ER, although these mechanisms remain poorly
defined. However, specific aspects of PDI function may offer the potential to be exploited
therapeutically in the future. This review will focus on the evidence linking ER stress
and the UPR to neurodegenerative diseases, with particular emphasis on the emerging
functions ascribed to PDI in these conditions.
Keywords: endoplasmic reticulum stress (ER stress), unfolded protein response (UPR), protein disulfide isomerase
(PDI), neurodegeneration, Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS),
Huntington’s disease (HD)
INTRODUCTION
The endoplasmic reticulum (ER) is a fundamental cellular organelle responsible for the folding,
post-translational modification, transportation, and quality control of newly synthesized proteins.
The ER is therefore a key component of cellular protein homeostasis, or proteostasis, integrated
mechanisms that control the regulation of protein trafficking, synthesis, folding, and degradation.
The maintenance and regulation of proteostasis is a critical function for post-mitotic cells such as
neurons and dysregulation of proteostasis is increasingly implicated in diseases that target neurons,
08 January 2016
Perri et al. The UPR and PDI
including neurodegenerative diseases. A pathological hallmark
of these diseases is the accumulation of misfolded protein
aggregates within affected neurons. Whilst neurodegenerative
diseases differ in the proteins which misfold, and the sub-groups
of neurons affected, abnormal protein misfolding is a common
feature.
When the accumulation of misfolded or unfolded proteins
occurs within the ER, this disturbs ER homeostasis, giving rise
to ER stress. ER stress results in activation of the unfolded
protein response (UPR) which aims to alleviate the stress. The
UPR involves up-regulation of protein chaperones to promote
protein folding, translational attenuation to reduce the load
of proteins within the ER to prevent further accumulation of
misfolded proteins, and up-regulation of ER-associated protein
degradation (ERAD) and autophagy to promote degradation of
misfolded proteins. Therefore, ER stress plays a pivotal role in
cell survival by maintaining proteostasis. In circumstances of
chronic or prolonged ER stress, however, the UPR becomes pro-
apoptotic, therefore triggering cell death. ER stress is increasingly
implicated as a key mechanism relevant to pathogenesis in
neurodegenerative diseases, although differential effects are
evident in different neurodegenerative conditions.
Chaperones promote the correct folding of proteins into their
native conformations and hence are an important mechanism
in proteostasis. One chaperone upregulated during the UPR is
Protein Disulfide Isomerase (PDI), which is found primarily
within the ER, but is also found in other cellular locations. PDI is
the prototype of a family of proteins that possess two alternative
functions; general chaperone activity and disulfide interchange
activity; in which protein disulfide bonds are oxidized, reduced,
or isomerized. As chaperones prevent protein misfolding, novel
therapeutic strategies mimicking the functional activity of PDI
may therefore be beneficial in disorders involving protein
misfolding. Consistent with this notion, there is increasing
evidence linking PDI to neurodegenerative diseases. Recent
studies have revealed unconventional roles for PDI in these
disorders, distinct from its normal function in the UPR and
the ER, although these mechanisms remain poorly defined. This
review will focus on the evidence linking ER stress and the UPR
to neurodegenerative diseases, with particular emphasis on the
role of PDI in these conditions.
NEURODEGENERATION
Neurodegenerative diseases have long been regarded as
intangible mysteries of biomedical research and targeting
these conditions therapeutically remains a major obstacle in
medicine. Whilst these disorders are distinct in their clinical
manifestations, they share a common pathological hallmark: the
abnormal aggregation of misfolded proteins (Lindholm et al.,
2006). Aggregation occurs when misfolded proteins expose
hydrophobic regions that are normally hidden within the protein
interior when folded in their native conformation. This exposure
of normally buried regions promotes hydrophobic interactions
with other proteins. Protein misfolding is triggered by genetic
mutations in familial forms of disease, or by cellular conditions
which cause wildtype proteins to misfold in sporadic forms of
disease, although the latter processes remain poorly defined.
The aggregation of misfolded proteins leads to the formation of
prominent protein inclusions (Wolozin, 2012; Figure 1). The
most prevalent neurodegenerative diseases include Alzheimer’s
disease (AD), Parkinson’s disease (PD), amyotrophic lateral
sclerosis (ALS), Huntington’s disease (HD), and transmissible
prion encephalopathies, such as Creutzfeldt-Jakob disease (CJD).
These disorders differ in the proteins that misfold and the group
of neurons which are affected (Soto, 2003;Table 1). An intriguing
puzzle is why specific groups of neurons are selectively targeted
in these conditions when the proteins that misfold are usually
FIGURE 1 | Schematic representation of the protein pathology
contribution to neurodegenerative disease via chronic Endoplasmic
Reticulum (ER) stress. Misfolded proteins aggregate and form prominent
inclusions as the characteristic pathological hallmark of these disorders. ER
stress results from the accumulation of misfolded proteins within the ER, thus
activating the Unfolded Protein Response (UPR), which if prolonged or
unresolved, can result in neuronal cell death, and hence neurodegenerative
disorders.
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TABLE 1 | Genes and proteins implicated in common neurodegenerative diseases.
Neurodegenerative disease Genes implicated in disease Proteins encoded References
Alzheimer’s disease APP Amyloid precursor protein Haass and Selkoe, 2007; Karran et al., 2011;
Matus et al., 2011PSEN1 Presenilin-1
PSEN2 Presenilin-2
MAPT Tau
Parkinson’s disease SNCA
PARK2
PINK1
PARK7
UCH-L1
PARK8
α-Synuclein
Parkin
PTEN-induced putative kinase 1
DJ-1
Ubiquitin carboxyl-terminal esterase L1
LRRK2
Chartier-Harlin et al., 2004; Schlehe et al., 2008;
Volpicelli-Daley et al., 2011
Amyotrophic lateral sclerosis SOD1 Cu/Zn superoxide dismutase 1 Ferraiuolo et al., 2011; Turner et al., 2013;
Leblond et al., 2014; Renton et al., 2014TARDBP TAR DNA binding protein 43 (TDP-43)
FUS Fused in sarcoma
C9orf72 Chromosome 9 open reading frame 72
ALS2 Alsin
SETX Senataxin
VAPB Vesicle-associated membrane
protein-associated B
OPTN Optineurin
VCP Valosin-containing protein
UBQLN2 Ubiquilin 2
PFN1 Profilin 1
SQSTM1 Sequestosome 1
HnRNPA2B1/A1 Heterogenous nuclear ribonucleoprotein
TAF15 TATA box binding protein-associated factor
Huntington’s disease HTT Huntingtin Carnemolla et al., 2009; Ross and Tabrizi, 2011
Creutzfeldt-Jakob disease PRNP PrP protein Head and Ironside, 2012; Porter and Leemans,
2013
expressed ubiquitously in all cell types. At the biochemical level,
however, these disorders share a commonmechanism; formation
of abnormal misfolded protein aggregates which lead to the
protein inclusions characteristic of pathology in these disorders.
Alzheimer’s Disease
AD is characterized by a progressive decline in memory,
language, behavior, and cognitive function (Salminen et al.,
2009). Neuronal degeneration in AD occurs in the cerebral cortex
(in particular the frontal, temporal, and parietal lobes) and the
hippocampus (Brundin et al., 2010; Fjell et al., 2014). Two types
of misfolded protein inclusions are present in these tissues.
Amyloid plaques are formed extracellularly by the aggregation
of β-amyloid, which is produced by abnormal cleavage of
amyloid precursor protein (APP), and neurofibrillary tangles,
which are formed intracellularly in the cytoplasm by hyper-
phosphorylation of themicrotubule associated protein tau (Haass
and Selkoe, 2007; Matus et al., 2011). Mutations that cause
familial cases of AD occur in genes encoding APP, or the
presenilin genes (PS1 and PS2) which encode proteins that
comprise the secretase complex that regulates APP processing.
These mutations alter the metabolism of β-amyloid, which either
increase the total production of β-amyloid or reduce its rate
of degradation. The increased levels of β-amyloid then lead
to its oligomerization (Haass and Selkoe, 2007; Karran et al.,
2011).
Parkinson’s Disease
PD results from the degeneration of dopaminergic neurons
primarily in the substantia nigra pars compacta in the midbrain
(Matus et al., 2011). As a consequence, PD patients experience
symptoms of motor dysfunction; tremors, bradykinesia (slowed
movement), rigidity, loss of autonomicmovement, and abnormal
gait (Jankovic, 2008). The most widely studied gene linked to
PD encodes α-synuclein, which causes rare autosomal dominant
familial forms of disease (Chartier-Harlin et al., 2004). α-
synuclein is found in both Lewy bodies and Lewy neurites, which
are protein inclusion bodies found in the neuronal cytoplasm and
processes, respectively (Volpicelli-Daley et al., 2011). Mutations
in the genes encoding Parkin, PINK1, and DJ-1, LRRK2 and
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UCH-L1 cause familial forms of PD, which arise through
autosomal recessive inheritance (Schlehe et al., 2008).
Amyotrophic Lateral Sclerosis
ALS is characterized by the degeneration of upper motor neurons
of the motor cortex and lower motor neurons of the brainstem
and spinal cord (Kent-Braun et al., 1998). Patients typically
experience symptoms of fatigue, muscle weakness and atrophy,
followed by paralysis (Rothstein, 2009; Robberecht and Philips,
2013). There are numerous genes linked to ALS both genetically
and/or pathologically (Leblond et al., 2014; Renton et al., 2014;
Table 1). Protein inclusions in ALS form in the cytoplasm of
degenerating motor neurons and depending on the patient,
contain primarily [Cu/Zn] superoxide dismutase 1 (SOD1), TAR
DNA binding protein 43 (TDP-43), fused in sarcoma (FUS), or by
dipeptide repeat proteins produced by non-conventional repeat
associated non-ATG translation, encoded by the Chromosome 9
open reading frame 72 repeat expansion (C9orf72) (Ferraiuolo
et al., 2011; Turner et al., 2013; Leblond et al., 2014; Renton et al.,
2014). Recent evidence has demonstrated that ALS is linked to
closely to frontotemporal dementia (FTD) (Ling et al., 2013).
Huntington’s Disease
Characterized by involuntary movements such as twitching and
chorea (jerky movements of limbs), personality changes and
dementia, HD is an autosomal dominant disease (Brundin et al.,
2010). Mutations in the huntingtin (Htt) gene result from
the expansion of a CAG repeat, which leads to an aberrantly
long polyglutamine sequence in the huntingtin protein (Ross
and Tabrizi, 2011). Huntingtin proteins with less than 35
polyglutamine repeats do not aggregate readily, however proteins
with more than 40 repeats result in aggregation into inclusion
bodies (Brundin et al., 2010). In general, longer lengths of
polyglutamine repeats result in more rapid neurodegeneration
and earlier disease onset than shorter repeats (Ross and Tabrizi,
2011). In contrast to the other neurodegenerative diseases in
which most cases (85–90%) are sporadic, HD is entirely genetic
in nature (Carnemolla et al., 2009).
Creutzfeldt-Jakob Disease and Other Prion
Encephalopathies
Transmissible prion encephalopathies are neurodegenerative
disorders in which proteins become infectious and protein
misfolding propagates from one cell to another. These infectious
proteins are termed prions (Makarava et al., 2012). The most
common transmissible prion encephalopathy is CJD, in which
patients experience memory loss, cognitive decline, personality
changes, and psychosis (Porter and Leemans, 2013). The
prion gene PRNP encodes cellular prion protein (PrPc), which
occurs naturally in both humans and animals. However, in
CJD, the accumulation of abnormal prion protein, the scrapie
isoform PrPSc, results, which is the major component of the
purified infectious agent (Head and Ironside, 2012). PrPSc
promotes refolding of natively folded PrPc proteins into disease-
associated misfolded PrPSc prions, resulting in insoluble protein
inclusions in the brain and lympho-reticular tissues (Porter and
Leemans, 2013). Not surprisingly, familial forms of CJD are
caused by mutations in the PRNP gene (Head and Ironside,
2012).
Proteins misfold as part of normal cellular physiology,
however normally, cells do not accumulate protein aggregates.
Hence, what causes the formation of protein inclusions in
neurodegeneration? A striking feature of neurodegenerative
diseases is that they are late onset, and the probability of
disease onset rises significantly with age. Therefore, pathology
can be hypothesized to arise as a consequence of the
normal aging process, whereby proteostasis becomes increasingly
more difficult for cells to maintain as misfolded proteins
continuously accumulate within the neuron. These mechanisms
are not well understood, although decreases in chaperone
activity or the efficiency of protein degradation processes
over time may accelerate the accumulation of misfolded
proteins (Nakamura and Lipton, 2011). Similarly, a decrease in
antioxidant defenses during normal aging results in increases in
the production of free radicals, therefore promoting oxidative
stress (Halloran et al., 2013). Oxidative stress ultimately damages
cells and is closely associated with ER stress (Lindholm
et al., 2006; Kanekura et al., 2009). We describe below the
increasingly complex relationship between the ER and protein
misfolding in the context of age-related neurodegenerative
disorders.
ER STRESS
The Endoplasmic Reticulum (ER) in
Neurons
The ER is the largest membrane-bound organelle in the cell,
and it possesses a diverse range of signaling and homeostatic
functions. As well as the synthesis, folding/maturation, and
trafficking of all secretory/transmembrane proteins, it also
synthesizes lipids, plays a critical role in Ca2+ homeostasis, and
is essential for compartmentalization of the nucleus and the
structure of chromatin. Recently, novel ER functions have been
described, including the regulation of mitochondrial function
and the formation of autophagosomes, thus highlighting the
importance of this organelle in cellular organization and
proteostasis. The ER is well characterized in yeast and specialized
secretory cells, but the ER in neurons is poorly studied
in comparison. It is clear, however that the ER is much
more extensive in neurons than in other cells, extending
throughout the entire dendritic arbor and axon (Ramirez et al.,
2011). There is evidence that multiple proteins are synthesized
locally in both dendrites and axons (Lin and Holt, 2008;
Yudin et al., 2008; Merianda et al., 2009). However, in these
compartments, in particular within the axon, the ER remains
largely uncharacterized.
Equipped with a variety of chaperones and folding enzymes,
the ER maintains tight quality control measures to sustain its
environment (Halperin et al., 2014). When nascent proteins
enter the ER, the formation of disulfide bonds and other
post-translational modifications facilitate correct protein folding.
Disulfide bond formation is catalyzed by the PDI family of
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proteins and is possible due to the oxidizing environment of
the ER (E◦′ = −0.18V ; Woycechowsky and Raines, 2000;
Wilkinson and Gilbert, 2004). These disulfide bonds ensure
protein structural stability and promote assembly of multi-
protein complexes (Woycechowsky and Raines, 2000). Correctly
folded proteins are transported to the Golgi apparatus, where
they are further sorted, modified and then packaged for secretion.
The ER-Golgi route is an important cellular pathway; one third of
all proteins transit the ER and Golgi compartments destined for
transmembrane, ER or extracellular locations (Ghaemmaghami
et al., 2003). Proteins which are unable to be correctly folded
are directed to Endoplasmic Reticulum-Associated Degradation
(ERAD), where misfolded proteins are transported to the cytosol
for degradation by the proteasome, or by autophagy (Hetz and
Mollereau, 2014).
The Unfolded Protein Response
The UPR is an adaptive mechanism designed to cope with
protein folding alterations in the ER, and thus restore
proteostasis (Walker, 2010). Under moderate misfolded protein
accumulation, the UPR transduces information from the ER to
the nucleus and cytosol and thereby inhibits protein translation,
expands the ER membrane, recruits ER chaperones to aid in
the correct folding of misfolded proteins, and promotes protein
degradation in order to reduce the load of unfolded or misfolded
proteins (Hetz, 2012). However, under conditions of chronic or
irreversible ER stress, such as in disease states, the UPR shifts
from being protective to pro-apoptotic, and multiple integrated
apoptotic pathways can trigger cell death (Figure 2).
The UPR is mediated by three ER stress sensors; PKR-like
endoplasmic reticulum kinase (PERK), inositol-requiring kinase
1 (IRE1), and activating transcription factor 6 (ATF6). These
ER stress sensors are bound to the ER chaperone, BiP, under
basal conditions, keeping them in an inactivated state. When ER
stress arises, for example, there is an accumulation of misfolded
proteins in the ER lumen, BiP dissociates from the ER stress
sensors to preferentially bind the hydrophobic regions of the
misfolded proteins, thus resulting in their activation (Rutkowski
et al., 2006).
In one pathway, upon activation, PERK directly
phosphorylates, and thus inhibits, the ubiquitous eukaryotic
translation initiation factor 2α (eIF2α). As a consequence, there
is a reduction in the entrance of newly synthesized proteins into
the ER lumen, therefore reducing the load of ER protein-folding
(Boyce et al., 2005). Phosphorylation of eIF2α also favors the
selective translation of the mRNA encoding the transcription
factor ATF4. ATF4 translocates to the nucleus where it induces
the expression of ER chaperones, such as PDI, which increases
refolding of misfolded proteins (Halperin et al., 2014). ATF4 also
induces the expression of various genes involved in autophagy,
antioxidant response, and amino acid biosynthesis and transport
(Cao and Kaufman, 2012; Hetz and Mollereau, 2014).
A second pathway of the UPR is initiated by IRE1 which is
activated upon its dimerization and auto-phosphorylation (Hetz,
2012). IRE1 degrades a subset of mRNAs which encode for
ER-localized proteins by means of regulated IRE1 dependent
decay (RIDD), thereby reducing protein synthesis in the ER
(Cao and Kaufman, 2012). IRE1 also catalyses the splicing of
the mRNA encoding transcription factor X-box binding protein
1 (XBP-1). This splicing removes a 26 base intron from XBP-1,
resulting in a shift in the reading frame of its mRNA (Hetz and
Mollereau, 2014). Spliced XBP-1 is a stable transcription factor
FIGURE 2 | The Unfolded Protein Response. Adapted from Hetz and Mollereau (2014). A schematic demonstrating the action of the three ER stress sensors on
the Unfolded Protein Response.
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which translocates to the nucleus to induce the upregulation
of ER chaperones and proteins involved in the ER-associated
degradation (ERAD) pathway. XBP-1 also controls phospholipid
synthesis which is important for ER membrane expansion when
the ER is under stress (Lee et al., 2003).
In a third pathway, upon UPR activation, ATF6 translocates
from the ER membrane to the Golgi apparatus where it is
cleaved by site-1 and site-2 proteases. The resulting cytosolic
ATF6 fragment (ATF6f) translocates to the nucleus to induce
gene expression of ER chaperones, ERAD components and XBP-
1 (Schröder and Kaufman, 2005). Together, the ER stress sensors
regulate the expression of a number of overlapping target genes,
encoding for proteins which modulate adaptation to stress, thus
promoting the survival of the cell.
Chronic Activation of the UPR
Under conditions of chronic or irreversible ER stress, such as
those that occur in disease, there is a shift in the paradigm
of the UPR from being pro-protective to pro-apoptotic. The
UPR therefore induces apoptosis mediated by overlapping
apoptotic signaling mechanisms (Ma and Hendershot, 2004).
Sustained activation of the ER stress sensor PERK elicits a
chain of transcriptional responses mediated by ATF4. ATF4
induces the upregulation of the transcription factor C/EBP-
homologous protein (CHOP) and its target growth arrest
and DNA damage-inducible 34 (GADD34). The promoter
of CHOP contains the binding sites for several players of
the UPR, including ATF4 and ATF6, and is a key mediator
of ER stress induced apoptosis (Cao and Kaufman, 2012).
CHOP can inhibit the expression of survival protein BCL-
2 and simultaneously engage pro-apoptotic proteins such
as Bcl2-interacting mediator of cell death (BIM) and p53
upregulated modulator of apoptosis (PUMA). The outcome
is the activation of BAX- and BAK- dependent apoptosis at
the mitochondria and the caspase cascade, which result in
apoptosis of the cell (Soo et al., 2009; Hetz and Mollereau,
2014). Furthermore, CHOP induces ERO1α which causes
oxidative stress by transferring electrons from PDI to O2 to
produce hydrogen peroxide. The activation of GADD34 results
in the dephosphorylation of eIF2α, thus increasing protein
synthesis and accentuating the ER and oxidative stress (Cao and
Kaufman, 2012). IRE1 also plays a role in apoptosis of a cell
through the recruitment of apoptosis signaling kinase (ASK1)
which activates the c-Jun N-terminal kinase (JNK) pathway,
which stimulates proinflammatory responses apoptotic pathways
(Nishitoh et al., 2002), and also by direct interaction with BAX
and BAK (Hetz et al., 2006). It is this apoptosis of cells which
results in the degeneration of motor neurons characteristic of
neurodegenerative diseases.
The UPR therefore constitutes a complex mechanism of
integrated signaling pathways that responds to ER stress by either
cellular adaptation, thus promoting the survival of the cell, or
by triggering apoptosis. Similar to other aspects of neuronal
ER biology, whilst the UPR is well-characterized in many cell
types, its function in neurons is poorly understood (Wang and
Kaufman, 2012) and the response of the UPR in the axonal
and dendritic compartments remains uncharacterized. Similarly,
it is unknown if the expression of UPR proteins is induced
locally or somally in response to neuronal activity. Whilst
mechanisms underlying the selective vulnerability of neurons
to degeneration remain unknown, an interesting possibility
is that the unique properties of the ER may contribute and
render neurons particularly sensitive to ER stress. However, this
possibility remains largely unexplored.
Protein Disulfide Isomerase
Structure and Expression of PDI
PDI is a 55kDa ER chaperone primarily localized in the ER
(Ellgaard and Ruddock, 2005), however it has also been detected
in the cytoplasm, nucleus and extracellularly in a biologically
active state (Turano et al., 2002). PDI has four distinct domains
within its structure; a, a’, b, and b’, with a highly acidic C-terminal
extension and an x linker region (Figure 3). An ER-retention
signal sequence (KDEL) lies at the C terminus (Hatahet and
Ruddock, 2007). The a and a’ domains are catalytic domains,
similar to thioredoxin, which are separated by the two non-
catalytic domains (b and b’) (Hatahet and Ruddock, 2007), that
only share 16.5% sequence identity (Xu et al., 2014). The catalytic
domains contain an active site motif comprising two cysteine
residues separated by glycine and histidine (Cys-Gly-His-Cys).
The oxidoreductase activity of PDI relies on the thiol groups of
these active site cysteines (Jessop et al., 2009). Each CGHC active
site has a high disulfide reduction potential (E◦′ = −0.18V) and
a low pKa value (pKa = 6.7) making it a competent oxidizing
agent in the ER (Woycechowsky and Raines, 2000; Liu et al., 2013;
Figure 3).
Functions of PDI
PDI has two major functions. Firstly, it is responsible
for the oxidation (formation), reduction (break down) and
isomerization (rearrangement) of protein disulfide bonds via
disulfide interchange activity (illustrated in Figure 4). Secondly,
PDI has general chaperone activity (Ferrari and Söling, 1999).
Disulfide interchange activity
The a and a’ domains of PDI operate independently of one
another, as disruption to one domain abolishes 50% of catalytic
activity. However, disruption to the active site of both domains
results in complete elimination of oxidoreductase activity (Xu
et al., 2014). The redox state of the active site cysteine residues
and the properties of its substrate determine whether PDI
acts as an oxidase, reductase, or isomerase (Xu et al., 2014).
In an oxidation reaction, whereby PDI mediates oxidative
FIGURE 3 | The structure of Protein Disulfide Isomerase (PDI). PDI has
four distinct domains, a, a’, b, and b’, as well as a linker region, “x”, and its
C-terminal extension with KDEL sequence. The catalytic domains, a and a’,
possess active sites containing the motif cysteine-glycine-histidine-cysteine
(CGHC). KDEL, the ER retention signal sequence.
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FIGURE 4 | Schematic representation of the disulfide interchange
activity of Protein Disulfide Isomerase (PDI). PDI can form, break down,
and rearrange disulfide bonds. This aids in promoting the formation of the
native conformation in a misfolded or unfolded protein. Adapted from Forrester
et al. (2006).
protein folding to form disulfide bonds in a nascent protein,
the substrate dithiol is oxidized to a disulfide. The substrate’s
reduced cysteine thiols bind with the CGHC motif disulfide
on PDI to form a PDI-protein complex. A second reduced
thiol from the protein substrate interacts with the complex
to produce an oxidized protein which is correctly folded and
stabilized. Simultaneously, the active site disulfide in PDI is then
reduced to the dithiol state (Forrester et al., 2006). When PDI
is reduced after donating a disulfide bond to nascent proteins,
it is subsequently reoxidized in the oxidizing environment of
the ER. Alternatively, cellular regulators, such as endoplasmic
reticulum oxidoreductin 1 (Ero1) interacts with, and reoxidises,
the reduced PDI (Mezghrani et al., 2001; Medraño-Fernandez
et al., 2014). Oxidative protein folding, however, is prone to
error and incorrectly folded proteins can arise as part of
normal physiology. Hence, non-native disulfide bonds need to
be corrected via isomerization, or reduced to produce the native
conformation (Wilkinson and Gilbert, 2004). In a reduction
reaction, whereby PDI breaks down disulfide bonds in protein
substrates, a substrate disulfide is reduced to the dithiol state,
while an active site disulfide is formed in PDI. Reductants such
as glutathione (GSH) and NADPH donate electrons to reduce
the disulfide in PDI back to its dithiol state (Xu et al., 2014).
When misfolded proteins form, isomerization of disulfide bonds
is required to convert the disulfides to their native conformation.
To facilitate isomerization, one of PDI’s active sites must be in a
reduced state (Medraño-Fernandez et al., 2014). Isomerization,
or the rearrangement of disulfide bonds in a substrate protein,
is initiated by the cysteine nearest the N-terminus at each
PDI active site (CGHC). This cysteine binds a substrate
disulfide which results in an intramolecular rearrangement
within the substrate itself. Conversely, isomerization can be
seen as repeated cycles of reduction and oxidation (Wilkinson
and Gilbert, 2004). Ultimately, the impairment of PDI’s activity
can lead to the accumulation of misfolded proteins, resulting
in ER stress and activation of the UPR (Forrester et al.,
2006).
Chaperone function
Chaperone binding keeps proteins soluble and competent to fold
in order to acquire their native structure (Kojer and Riemer,
2014). As a chaperone, PDI binds to misfolded proteins to
prevent them from aggregating and targets misfolded proteins
for degradation (Ma and Hendershot, 2004). Although all of the
domains of PDI contribute to the binding of misfolded proteins,
the b’ domain comprises the principal substrate-binding site,
utilizing hydrophobic interactions to exhibit high affinity and
broad specificity (Xu et al., 2014).
S-Nitrosylation of PDI
Cellular redox states normally regulate cellular function and
maintain homeostasis, but when redox homeostasis is disturbed,
neurodegeneration can result. The ER is able to withstand mild
insults of stress, however a build-up of reactive oxidative species
(ROS) and reactive nitrogen species can result in oxidative and
nitrosative stress in the ER (Halloran et al., 2013). Neurons
are particularly vulnerable to redox dysregulation due to their
large size and high oxygen consumption (Parakh et al., 2013).
In addition, normal antioxidant defenses usually decline during
the normal aging process and hence nitrosative and oxidative
stress increases, thus rendering neurons susceptible to age-
related degenerative conditions (Halloran et al., 2013). The
excessive generation of nitric oxide (NO) has been implicated
in AD, PD, and ALS (Forrester et al., 2006). In AD, elevated
levels of oxidative and nitrosative stress are associated with
alterations in amyloid-β metabolism (Mangialasche et al.,
2009).
In conditions of elevated nitrosative stress, the active sites
of PDI undergo an aberrant post-translational modification—
S-nitrosylation—which prevents its normal enzymatic function
(Forrester et al., 2006). Specifically, s-nitrosylation is the covalent
addition of a nitric monoxide group to a cysteine thiol on PDI’s
active site, hence inhibiting its normal protective function, and
resulting in the accumulation of misfolded proteins (Forrester
et al., 2006). Uehara et al. (2006) demonstrated that PDI is
s-nitrosylated in AD and PD patient brains, but not in that
of healthy controls. Similarly, s-nitrosylated PDI levels in the
lumbar spinal cords of ALS patients were approximately 5-
fold greater compared to those of controls (Walker et al.,
2010). S-nitrosylated PDI was also reported both in the brains
of PrPSc infected rodents and in cell models of CJD bearing
PrPSc misfolded proteins (Wang et al., 2012). Wu et al.
(2014) investigated the effects of methamphetamine in cellular
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 January 2016 | Volume 3 | Article 80
Perri et al. The UPR and PDI
models of PD on the basis that methamphetamine users
pose a higher risk of developing neurodegenerative disorders.
A significant increase in the levels of nitric oxide synthase
(NOS), NO and α-synuclein 24 h after methamphetamine
treatment was reported in these cells (Wu et al., 2014). These
changes to the nitrosative state of the cells resulted in the
augmented aggregation of α-synuclein and the s-nitrosylation
of PDI, suggesting that PDI could be a potential target
to prevent methamphetamine-induced neurodegeneration (Wu
et al., 2014). Furthermore, S-nitrosylated PDI was detected
following ischemia/reperfusion injury and the levels increased
with the formation of mutant SOD1 aggregates in primary
astrocytes (Chen et al., 2012). Similarly, S-NO PDI correlates
with synphilin misfolding in Parkinson disease (Forrester et al.,
2006). S-nitrosylation is also involved in the re-distribution
of PDI away from the ER by reticulons which maintain the
curvature of the ER (Bernardoni et al., 2013). The deletion of
reticulon 4A is protective in mouse models of ALS (Yang et al.,
2009).
PDI Family Members
The PDI family contains over 21 structurally-related members
that constitutes a network of proteins which promote the
oxidative folding of multi-disulfide proteins (Kojima et al., 2014;
selected members are highlighted in Figure 5). All members
contain two ormore thioredoxin-like active sites and themajority
of members in this family also act as chaperones (Turano et al.,
2002). The most common active site motif amongst PDI family
members is CGHC, which is present in PDI, ERp57, and ERp72
(Figure 4). ERp57 is the closest known homolog of PDI. It has the
same domain structure as PDI, but it lacks the C-terminal acidic
region (Frickel et al., 2004).
EVIDENCE FOR INDUCTION OF THE UPR
IN NEURODEGENERATIVE DISEASES
There is increasing evidence that activation of the UPR is a
feature of most neurodegenerative disorders. The most obvious
association between ER stress and neurodegeneration is via
chronic UPR activation during disease, thus triggering apoptosis
and neuronal cell death. The up-regulation of UPR markers in
disease-affected neurons has now been described in cellular and
animal models of disease, as well as in post-mortem human
tissues, for most of these disorders. The initial participation of
the UPR in pathogenesis might be neuroprotective as has been
proposed in recent studies, but sustained activation of the UPR
may subsequently initiate or accelerate neurodegeneration. In
some instances the misfolded proteins are present within the
cytoplasm rather than the ER, and can trigger ER stress by
indirect mechanisms, that nevertheless disrupt ER homeostasis
(Nishitoh et al., 2008; Atkin et al., 2014). Together, these studies
suggest that the UPR pathway may be a potential therapeutic
target for neurodegenerative diseases. Recent developments in
the use of human neurons derived from reprogrammed induced
pluripotent stem cells (iPSCs) provide a useful tool to unravel
pathological mechanisms in these disorders, and ER stress and
activation of the UPR are increasingly implicated in these studies
(Table 2).
Alzheimer’s Disease
Whilst initial reports were contradictory, there is now convincing
evidence for ER stress and UPR activation in AD, with
recent studies suggesting that ER stress has a fundamental
role in AD etiology. Hoozemans et al. (2005) demonstrated
that the expression of ER chaperone, BiP, and the activated,
phosphorylated form of UPR sensor PERK, were significantly
increased in the temporal cortex and hippocampus in AD
patients compared to controls. Furthermore, in a later study the
same group reported upregulation of PERK, IRE1 and eIF2α in
neurons of the hippocampus in AD patients; in particular, in
neurons with granulovacuolar degeneration (Hoozemans et al.,
2009). Evidence for pro-apoptotic UPR in AD was reported by
Ghribi et al. (2004), when CHOP and JNK were up-regulated
in animal disease models. Similarly, CHOP activation was
detected in neuronal cells treated with Aβ (Chafekar et al.,
2008). Lee and colleagues (2010a) detected increased levels of
FIGURE 5 | Selected members of the Protein Disulfide Isomerase (PDI) family of chaperones and representation of their different domains. Most PDI
family members possess disulfide interchange activity and many contain the CGHC motif similar to that of PDI.
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TABLE 2 | Evidence for ER stress and the role of PDI in neurodegenerative diseases.
Neurodegenerative disease Protein inclusions Evidence for ER stress Evidence for a role of PDI
Alzheimer’s disease (AD) β-Amyloid Tau BiP, PERK, IRE1, and eIF2α upregulated in AD
patients (Hoozemans et al., 2005, 2009).
Cleaved caspases and JNK upregulated in AD
patients (Ghribi et al., 2004; Lee et al., 2010a).
CHOP upregulated in AD animal models and cell
models treated with β-amyloid, and in AD patients
(Ghribi et al., 2004; Chafekar et al., 2008; Lee et al.,
2010a).
IPSC-derived neurons and astrocytes from AD
patients accumulate Aβ oligomers (Kondo et al.,
2013).
PDI co-localizes with tau protein (Honjo
et al., 2010).
PDI levels increase 9.49 fold in
tangle-bearing neurons in AD patients (Lee
et al., 2010a).
β-amyloid co-localizes with ERp57
(Erickson et al., 2005).
Pharmacological activation of ERp57
reduces amyloid plaques and
neurofibrillary tangles in brains, and
improved object recognition memory in AD
mouse models (Tohda et al., 2012).
Parkinson’s disease (PD) α-Synuclein Upregulation of IRE1, PERK, eIF2α, and ATF4 in PD
cell models (Ryu et al., 2002).
Phosphorylated PERK and phosphorylated eIF2α
detected in dopaminergic neurons of PD patients
(Hoozemans et al., 2007).
Co-localization of phosphorylated PERK and
α-synuclein in dopaminergic neurons (Hoozemans
et al., 2007).
CHOP upregulation in dopaminergic neurons of
mouse models and in cell models (Ryu et al., 2002;
Holtz and O’Malley, 2003; Silva et al., 2005).
Upregulation of PDIA2 in PD cell models
and post-mortem brain tissues of PD
patients (Conn et al., 2004).
PDIA2 immunoreactivity evident in Lewy
Bodies (Conn et al., 2004).
PDI upregulated in PD cell models (Ryu
et al., 2002).
Amyotrophic lateral sclerosis (ALS) SOD1 TDP-43 FUS C9orf72 UPR and CHOP induced prior to symptom onset in
SOD1G93A mouse models (Atkin et al., 2006;
Kikuchi et al., 2006; Saxena et al., 2009).
PERK, IRE1 and ATF6 upregulated in post-mortem
human spinal cord tissues (Atkin et al., 2008).
Deletion of BIM, XBP-1, ASK1, Puma or ATF4 delays
disease onset or extends survival in ALS mouse
models (Kieran et al., 2007; Nishitoh et al., 2008;
Hetz et al., 2009; Matus et al., 2013a,b).
Pharmacological inhibition of eIF2α
dephosphorylation extends survival of ALS mouse
models (Boyce et al., 2005; Saxena et al., 2009).
PDI upregulated in SOD1G93A mouse
models at presymptomatic, symptomatic
and end stages of disease (Atkin et al.,
2006, 2008).
PDI co-localizes with inclusions in ALS
mouse models, cell models and ALS
patients (Atkin et al., 2006, 2008; Tsuda
et al., 2008; Honjo et al., 2011; Farg et al.,
2012; Walker et al., 2013).
PDI and ERp57 upregulated in ALS patient
and mouse model spinal cord tissues and
patient CSF (Atkin et al., 2006, 2008).
PDI over expression decreases mutant
SOD1 inclusion formation, BiP and CHOP
expression and PERK phosphorylation in
ALS cell models (Walker et al., 2010).
PDI knock down increases mutant SOD1
inclusion formation in ALS cell models
(Walker et al., 2010).
Huntington’s disease (HD) Huntingtin BiP and CHOP upregulated in post-mortem brains
from HD patients and in HD cell models (Duennwald
and Lindquist, 2008; Carnemolla et al., 2009).
BIM upregulated in HD animal and cells models
(García-Martínez et al., 2007; Kong et al., 2009; Leon
et al., 2010).
XBP-1 upregulated in striatum of HD patients (Vidal
et al., 2012).
XBP-1 knock down reduced neuron loss and mHtt
levels, and improved motor performance in HD
mouse models (Vidal et al., 2012).
Increased basal expression of PDI in HD
cell models (Duennwald and Lindquist,
2008).
PDI elevated in hippocampus of HD
mouse models (Safren et al., 2014).
Creutzfeldt-Jakob disease (CJD) Prion protein Upregulation of caspase-12 in CJD cell models and
post-mortem patient cortex tissues (Hetz et al.,
2003).
Upregulation of ERp57, Grp94 and BiP in HD cell
models and patient cortex tissues (Hetz et al., 2003).
Increased intracellular calcium release from the ER
(Torres et al., 2010).
PDI overexpression in brains of CJD
patients (Yoo et al., 2002).
Increased expression of ERp57 (Hetz
et al., 2005).
ERp57 overexpression protects cells from
PrPsc toxicity and decreases rate of
caspase-12 activation (Hetz et al., 2005).
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cleaved caspase-12, cleaved caspase-3, cleaved caspase-4, and
CHOP in the temporal cortex of AD patients. In vitro studies
involving neuronal cells in culture exposed to Aβ oligomers,
suggested that the ensuing activation of ER stress correlates
with the induction of Tau phosphorylation, thus providing an
interesting link between ER stress, Aβ-mediated neurotoxicity
and Tau hyperphosphorylation (Resende et al., 2008; Ferreiro
and Pereira, 2012). However, whilst UPR activation can induce
Tau phosphorylation, Tau phosphorylation may not activate
ER stress (Sakagami et al., 2013). Modulation of the UPR can
also be protective in AD cellular and animal models. PERK
knockdown in neuronal cells enhanced Aβ toxicity through
reduced activation of eIF2α (Lee et al., 2010b). Furthermore,
activating the eIF2α pathway with Salubrinal significantly
reduced caspase-4 dependent apoptosis in Aβ treated neurons
(Lee et al., 2010b). These results suggest that the PERK-eIF2α
pathway may play a role in cell survival, rather than apoptosis
during ER stress. Interestingly, pathological events described in
AD, such as neurofibrillary tangles, neuroinflammation, altered
calcium signaling, and excitotoxicity, were also recently linked
to the occurrence of pathological ER stress (Cornejo and Hetz,
2013). Similarly, IPSC-derived neurons and astrocytes from
APP-linked familial and sporadic AD patients accumulated Aβ
oligomers, leading to ER and oxidative stress (Kondo et al.,
2013). ER stress was recently shown to promote cholesterol
synthesis and mitochondrial cholesterol trafficking in AD mouse
models (Barbero-Camps et al., 2014). It has also been proposed
that ER stress may interfere with the normal trafficking of
APP through the normal secretory pathway, leading to the
production of Aβ, and subsequent toxicity (Plácido et al.,
2014).
Parkinson’s Disease
There is compelling evidence that ER stress is linked to
death of dopamine neurons in PD, although most of this
has been obtained from cell culture studies. However, in the
substantia nigra of PD patients, Hoozemans et al. (2007)
demonstrated immunoreactivity for PERK and eIF2α in
their phosphorylated, active forms in dopaminergic neurons.
Moreover, phosphorylated PERK was co-localized with increased
α-synuclein immunoreactivity in dopaminergic neurons,
suggesting a close association between UPR activation and the
aggregation of α-synuclein (Hoozemans et al., 2007). Ryu et al.
(2002) demonstrated that IRE1 and PERK were up-regulated
in cell culture models that mimic the selective dopaminergic
neuron degeneration that occurs in PD, as well as downstream
targets, eIF2α, ATF4 and CHOP. Holtz and O’Malley (2003)
screened dopaminergic neuroblastoma MN9D cells exposed
to either 6-OHDA or MPP+ and noted that the most highly
expressed transcript in both cases encodes for CHOP. Supporting
this finding, Silva et al. (2005) demonstrated induction of CHOP
in dopamine neurons of the substantia nigra in mouse models
following intrastriatal injection of 6-OHDA (Silva et al.,
2005). Similarly, overexpression of BiP or pharmacological
modulation of the UPR in α-synuclein transgenic mice was
protective (Colla et al., 2012; Gorbatyuk et al., 2012). More
recently, cortical neurons generated from iPS cells of patients
with α-synuclein mutations, identified ER stress as an early
pathogenic phenotype (Chung et al., 2013). Interestingly,
another recent study detected aberrant modification of ER stress
sensors IRE1α and PERK by NO-mediated S-nitrosylation,
in cell based models of PD. This resulted in loss of normal
enzymatic function, leading to dysfunctional ER stress signaling
and neuronal cell death Nakato et al. (2015). In contrast,
other studies have demonstrated that some aspects of the
UPR may be protective in PD. Overexpression of XBP-1 in
MPP+-induced cell models was protective by suppressing
apoptosis in cells exposed to proteasome inhibitors (Sado
et al., 2009). Similarly, transplanting neural stem cells into the
right lateral ventricles of rodents with rotenone-induced PD
resulted in higher rates of survival in XBP-1 transfected neural
stem cells compared to non-transfected cells (Si et al., 2012).
Additionally, dopamine levels in the substantia nigra were
significantly increased, α-synuclein expression was decreased,
and neurological symptoms were significantly improved,
following the transplantation of XBP-1 transfected neural
stem cells (Si et al., 2012). The results of these studies suggest
that XBP-1 enhancement is a possible therapeutic strategy for
PD.
Amyotrophic Lateral Sclerosis
Activation of the UPR is now well documented in cellular and
animal models of ALS and in human patient tissues. Studies
of transgenic mice expressing mutant SOD1G93A, a widely
used disease model, revealed that UPR sensors, chaperones
and apoptotic effectors were up-regulated in lumbar spinal
cords during disease (Atkin et al., 2006; Kikuchi et al., 2006).
Furthermore, the UPR was induced 60 days prior to symptom
onset, and was present initially in those subtypes of motor
neurons that degenerate first in ALS, indicating an active role
for ER stress in pathogenesis (Saxena et al., 2009). Whilst
SOD1 mutations represent only 2% of all ALS, and may not
accurately represent pathology in the more common forms of
disease, similar findings were obtained in post-mortem human
spinal cord tissues of sporadic ALS patients (Ilieva et al., 2007;
Atkin et al., 2008; Ito et al., 2009), thus placing ER stress on
a more generic pathophysiology for ALS. For example, PERK,
IRE1, and ATF6 are all upregulated in post-mortem human
spinal cord tissues (Atkin et al., 2008). More recently, ER stress
has been detected in neuronal cells expressing ALS-associated
mutants of FUS and TDP-43 (Farg et al., 2012; Walker et al.,
2013) and in animal models based on TDP-43 (Walker et al.,
2013). Similarly, the UPR is induced in cell culture by ALS-
associated mutant VAPB (Suzuki et al., 2009) and hexanucleotide
repeat expansions in C9ORF72 (Zhang et al., 2014). Several
mechanisms have been proposed for induction of ER stress in
ALS, including impairment of ERAD by binding to Derlin-
1 (Nishitoh et al., 2008) or impairment of protein transport
between the ER and Golgi apparatus (Sundaramoorthy et al.,
2013; Atkin et al., 2014). These studies implicate triggering of ER
stress from the cytoplasm rather than the ER, although mutant
TDP-43 and mutant FUS were recently shown to be associated
with the ER (Soo et al., 2015) The same study also demonstrated
that overexpression of Rab1, an intracellular vesicle trafficking
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regulator which plays a central role in UPR homeostasis,
prevented ER stress in cells expressing mutant SOD1, TDP-43
and FUS. Furthermore, the presence of Rab1-positive inclusions
in the motor neurons of human spinal cord tissues from sALS
patients implies that Rab1 is misfolded and loses its normal
vesicular distribution in sALS (Soo et al., 2015). Interestingly,
Rab1 dysfunction has also been linked to PD (Cooper et al., 2006).
In more recent studies, using reprogrammed IPS cells, ER stress
was closely associated with the electrical excitability of motor
neurons (Kiskinis et al., 2014), and that hyperexcitability may
trigger ER stress (Wainger et al., 2014).
Several studies have demonstrated that modulation of the
UPR genetically is protective in animal models of ALS. Deletion
of BIM, XBP-1, ASK1, Puma or ATF4 either delays disease
onset (Kieran et al., 2007; Matus et al., 2013a,b) or extends
survival in transgenic mutant SOD1 mice (Nishitoh et al., 2008;
Hetz et al., 2009). Similarly, pharmacological modulation of
the UPR is protective in SOD1G93A mice (Saxena et al., 2009),
and either C.elegans and zebrafish expressing mutant TDP-43
(Vaccaro et al., 2013). However, SOD1G85R mice with hemizygous
deletion of PERK had a substantially accelerated disease
onset and shortened lifespan compared to SOD1G85R/PERK+/+
controls (Wang et al., 2011), indicating that some aspects
of UPR induction are protective against disease. Similarly,
pharmacological inhibition of eIF2α dephosphorylation using
salubrinal delays disease and extends survival of SOD1G93A mice
(Boyce et al., 2005; Saxena et al., 2009) and decreased GADD34
slows disease progression and extends survival in this animal
model (Wang et al., 2013). Together, these findings imply that
PERK is a mediator of motor neuron survival in ALS, possibly
by decreasing protein misfolding (Wang et al., 2011, 2013) or by
inducing autophagy (Hetz et al., 2009). These results therefore
highlight the opposing protective and pro-apoptotic properties
of the UPR and suggest that selective targeting of specific
components of the UPR could be beneficial in ALS.
Huntington’s Disease
Evidence of induction of ER stress in human HD patients was
provided by Carnemolla et al., where BiP and CHOP were up-
regulated in post-mortem brains from HD patients (Carnemolla
et al., 2009). Similarly, increased expression of XBP-1 was
detected in the striatum of HD cases, although other markers
(CHOP, ATF4, and GRP78) were not elevated (Vidal et al.,
2012). ER stress is also detected early in HD mouse models
and persists throughout the lifespan of these animals, similar to
ALS rodent models (García-Martínez et al., 2007; Duennwald
and Lindquist, 2008; Carnemolla et al., 2009). Duennwald and
Lindquist (2008) demonstrated that in a striatal cell line derived
from Htt knock-in mice, increased basal expression of UPR
proteins BiP, CHOP and PDI was observed compared with
control cells (Duennwald and Lindquist, 2008). The same study
showed that toxic polyglutamine expansion repeats impaired
ERAD and degradation pathways (Duennwald and Lindquist,
2008). This suggests that the polyglutamine repeat expansion of
mutant Huntingtin compromises the proteasomal degradation
of misfolded proteins in the ER, thus giving rise to ER stress.
The induction of the pro-apoptotic protein BIM has also been
linked to HD in both animal (García-Martínez et al., 2007) and
cellular disease models (Kong et al., 2009; Leon et al., 2010).
Additionally, caspase-12 and the JNK pathway were activated in
cells expressing expanded polyglutamine aggregates. These data
together suggest ER stress is linked to cell death in HD (Kouroku
et al., 2002). ER stress has also been linked to motor phenotypes
in HD. Silencing XBP-1 expression in mutant Htt (mHtt)
transgenic mouse strain YAC128 reduced the loss of neurons
in the striatum, decreased mHtt levels, and improved motor
performance (Vidal et al., 2012). Conversely, ATF4 deficiency did
not alter mHtt levels, highlighting the involvement of XBP-1 in
HD pathogenesis (Vidal et al., 2012). Hence, whilst the XBP-1
pathway of the UPR is protective in PD, the opposite appears to
be true in HD.
Creutzfeldt-Jakob Disease
Upregulation of caspase-12, ERp57, Grp94, and BiP was
described by Hetz and colleagues in the cortex of post-mortem
sporadic CJD and variant CJD patients compared to controls
(Hetz et al., 2003). However, whether caspase-12 plays a role
in neurodegeneration is controversial. Nevertheless, in neuronal
cell cultures, PrPSc toxicity in CJD is associated with an increase
in the release of intracellular calcium from the ER and the
upregulation of ER chaperones, indicating a role for ER stress in
prion diseases (Hetz et al., 2003; Torres et al., 2010). Similarly,
prion replication and the expression of mutant PrP dysregulated
ER calcium homeostasis, giving rise to ER stress in cell culture
(Torres et al., 2010). Finally, another study showed that treatment
of Neuro-2A cells with PrPSc resulted in the activation and
upregulation of caspase-12 and significant upregulation of ER
chaperones, ERp57, Grp94, and BiP (Hetz et al., 2003).
PDI IN NEURODEGENERATIVE DISEASES
As PDI can facilitate protein folding, it is not surprising that
PDI is increasingly implicated in neurodegenerative diseases
where protein misfolding is a key component (summarized in
Table 2). PDI is often found co-localized with misfolded proteins
in disease-affected tissues, implying a possible role for PDI in
preventing protein misfolding (Atkin et al., 2006; Honjo et al.,
2010, 2011; Farg et al., 2012; Walker et al., 2013). In some
diseases, there is direct evidence that PDI prevents aggregation
and associated-toxicity, thus raising the likelihood that PDI is a
possible therapeutic target in neurodegeneration. Interestingly,
a recent study provided evidence that PDI family member
Erp57 can also mediate neurite outgrowth in neurons, thus
adding further complexity to the functions of PDI in relation
to neurodegeneration (Castillo et al., 2015). However, PDI is
often S-nitrosylated in these disorders, which would prevent its
normally protective function (Uehara et al., 2006).
PDI in Alzheimer’s Disease
Honjo et al. (2010) identified neurofibrillary tangles in the brains
of patients with AD in which PDI was co-localized with tau. The
levels of PDI were also markedly increased (up to 9.5 fold) in
neurofibrillary tangle-bearing neurons in AD brains compared
with those of age-matched controls and immunohistochemistry
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showed that PDI was primarily expressed in temporal cortex
neurons in AD patients (Lee et al., 2010a). Immunoblotting
studies of cerebrospinal fluid (CSF) from control patients
indicated that a vast concentration of β-amyloid is normally
bound to ERp57, forming a ERp57-β-amyloid complex (Erickson
et al., 2005). This finding therefore implies that PDI family
members normally prevent the aggregation of β-amyloid.
Consistent with this notion, pharmacological activation of ERp57
using Disogenin significantly reduced amyloid plaques and
neurofibrillary tangles in the cerebral cortex and hippocampus
of a mouse model of AD, in which five familial AD human
APPmutations were co-expressed (Tohda et al., 2012).Moreover,
performance of object recognition memory was significantly
improved in this mouse model, providing further evidence for
a protective role for ERp57 (Tohda et al., 2012).
PDI in Parkinson’s Disease
Conn et al. (2004) demonstrated an upregulation of PDI family
member PDIA2 in SH-SY5Y human neuroblastoma cells exposed
to MPP+, but not other family members PDI, ERp57 and
ERp72. Similarly, PDIA2 was upregulated in post-mortem brain
tissues from PD patients and immunohistochemical studies
demonstrated that PDIA2 immunoreactivity was evident in Lewy
bodies of these patients (Conn et al., 2004). Unlike in SH-
SY5Y cells, PDI is upregulated in PC12 cells exposed to MPP+,
rotenone and 6-Hydroxydopamine (Ryu et al., 2002).
PDI in Amyotrophic Lateral Sclerosis
PDI is upregulated in the spinal cords of SOD1G93A mouse
models of ALS at presymptomatic (p60), symptomatic (p90),
and end stages (p120) of disease, and in human patient spinal
cords (Atkin et al., 2006, 2008). Similarly, ERp57 is upregulated
in SOD1G93A mouse models at similar time points and in
human patient tissues (Atkin et al., 2006). Furthermore, PDI
associates with abnormal inclusions in SOD1G93A mouse models
and neuronal cells in culture (Atkin et al., 2006), as well as in ALS
patients (Atkin et al., 2008). PDI also co-localizes with inclusions
formed by other ALS-linked proteins, TDP-43 (Honjo et al., 2011;
Walker et al., 2013), FUS (Farg et al., 2012) and vesicle associated
membrane protein (VAPB) (Tsuda et al., 2008), implying that
PDI is linked to general protein misfolding in ALS. PDI over-
expression decreased mutant SOD1 aggregation and inclusion
formation in neuronal cells and decreased BiP and CHOP
expression as well as PERK phosphorylation, in comparison
to controls, indicating that PDI is also protective against ER
stress (Walker et al., 2010). Furthermore, knock down of PDI
increased the formation of mutant SOD1 inclusions (Walker
et al., 2010). These data together suggest a protective role for
PDI against abnormal protein aggregation and ER stress in ALS.
This neuroprotection is further supported by the deletion of a
PDI regulator, Reticulon-4A, which accelerates the degeneration
of motor neurons in SOD1 mice models (Yang et al., 2009).
Quantitative western blotting also revealed an upregulation of
PDI in the CSF of ALS patients in comparison to controls (Atkin
et al., 2008). This finding may explain why PDI is subsequently
found in numerous cellular locations and secreted by various cell
types, instead of being localized exclusively to the ER (Turano
et al., 2002).
The profile of PDI in ALS has increased recently by the
identification of PDI variants as a genetic risk factor for the
disease. Kwok et al. (2013) reported that single nucleotide
polymorphisms (SNPs) in the P4HB gene encoding PDI were
associated with fALS and sALS. They reported significant
genotypic associations for two SNPS, rs876016, and rs2070872,
in fALS and significant allelic associations for rs876016 with
both sporadic and familial forms, suggesting that these SNPs
are risk factors for ALS (Kwok et al., 2013). Additionally, a
more recent study by Yang and Guo (2015) examined these
same two SNPs in sALS patients in the Chinese Han population.
They demonstrated a significant association of these SNPs with
sALS, implying that genetic variants in the P4HB gene may
be a contributing factor for sporadic forms of ALS in the
Chinese Han population. A further study by Gonzalez-Perez
et al. (2015) identified 16 variants in PDI and ERp57, with
1-2% present in all fALS and 1% present in all sALS cases
analyzed. This frequency is similar to that of other ALS-linked
gene variants (Turner et al., 2013). Structural analysis of PDI
variants predicted a change in the catalytic functioning of these
proteins, and changes in the structure of ERp57 variants are
thought to affect the calnexin-calreticulin cycle (Gonzalez-Perez
et al., 2015).
PDI in Other Neurodegenerative Diseases
Upregulation of PDI is also implicated in HD and prion
encephalopathies. Cells expressing polyglutamine expansion Htt
repeats exhibited elevated PDI levels when compared to control
cells expressing Htt with 25 repeats (Duennwald and Lindquist,
2008). Similarly, PDI was elevated in the hippocampus of
transgenic mouse models of HD when compared to wildtype
mice (Safren et al., 2014).
Yoo et al. (2002) observed an overexpression of PDI in
the brains of CJD patients. Hetz et al. (2005) observed an
upregulation of ERp57 in PrPsc toxicity and also reported that
ERp57 overexpression protected cells against PrPsc toxicity and
decreased the rate of caspase-12 activation (Hetz et al., 2005).
Similarly, inhibition of ERp57 expression led to a significant
increase in PrPsc toxicity (Hetz et al., 2005). A study by Wang
et al. (2012) evaluated the levels of some PDI family members
in brain tissues of rodents infected with scrapie strain 263K.
Western blot analysis revealed a significant upregulation in the
expression of PDI, ERp57 and BiP, and a significant decrease
in the levels of caspase-3. Increases in PDI and BiP were also
observed in cells expressing PrP mutants, and furthermore,
overexpression of PDI reduced ER stress and cytotoxicity in these
cell models (Wang et al., 2012).
Recent Developments in PDI Function
Associated with Neurodegeneration
Although PDI is generally associated with a protective effect in
maintaining proteostasis, recent studies have suggested that in
some circumstances, PDI activity can be detrimental and can
even trigger apoptosis. This pro-apoptotic function of PDI is
specifically associated with the presence of misfolded proteins:
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expression of mutant huntingtin resulted in accumulation of
PDI at ER-mitochondrial junctions and apoptotic cell death
(Hoffstrom et al., 2010). Furthermore, inhibitors specifically
targeting PDI reduced cellular toxicity induced by mutant
Huntington (Hoffstrom et al., 2010). These data therefore point
to a novel mechanism linking protein misfolding to apoptotic
cell death induced by PDI. Other recent studies suggest that PDI
can induce oxidative stress. PDI interacts with NADPH oxidase
and overexpression of PDI leads to increased levels of ROS and
apoptosis (Paes et al., 2011). Over-expression of PDI also appears
to induce oxidative stress in microglial cells in SOD1G93A mice
(Jaronen et al., 2013). The S-nitrosylation of PDI is also associated
with potentially damaging consequences. Wang et al. (2012)
found that S-NO PDI plays an essential role in the cytotoxicity
induced by PDI. The opposing effects of PDI, both protective and
harmful, were recently reviewed, and the reader is directed to this
for further information (Parakh and Atkin, 2015).
CONCLUSION
ER stress has been widely studied in neurodegenerative diseases,
and emerging evidence highlights the complexity of the UPR
in these disorders, with both protective and detrimental
components being described. Despite having different clinical
manifestations, neurodegenerative diseases are similar in
pathology; that is, an accumulation of misfolded proteins in
neurons and subsequent disruption to cellular proteostasis. The
PDI proteins are a large family of chaperones with complex
functions which offer the potential to be exploited therapeutically
in the future. However, the great complexity of the ER within
neurons, particularly in the dendrite and axonal compartments,
is only just becoming realized. Further studies in this area are
warranted before the true contribution of the UPR and ER
homeostasis to pathology can be appreciated.
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